<DOC>
	<DOCNO>NCT02555787</DOCNO>
	<brief_summary>A study evaluate change time renal function baseline ( time conversion ) five year post conversion kidney transplant patient convert tacrolimus twice daily ( BD ) formulation daily formulation Advagraf .</brief_summary>
	<brief_title>Global , Multicentre , Non Interventional Advagraf Conversion Registry Kidney Transplant Patients</brief_title>
	<detailed_description>This multicenter long-term ( five year post-conversion ) , non-interventional registry kidney transplant patient convert tacrolimus BD Advagraf . Centers provide medical care kidney transplant patient may convert patient tacrolimus BD Advagraf identify request approach patient consent participate .</detailed_description>
	<mesh_term>Tacrolimus</mesh_term>
	<criteria>Adult kidney transplant patient tacrolimus BD identify conversion Advagraf . Patients approach participate registry physician make decision convert Advagraf . Patients previously treat Advagraf stop reason exclude registry provide physician decide convert . Patients currently take Advagraf treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>FK506E</keyword>
	<keyword>Tacrolimus</keyword>
	<keyword>Observational</keyword>
	<keyword>Kidney transplantation</keyword>
	<keyword>Advagraf</keyword>
</DOC>